Legal Representation
Attorney
Michele M. Simkin
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 24, 2010 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Apr 7, 2008 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Mar 5, 2008 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| Mar 9, 2008 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Jan 14, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 14, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 14, 2008 | CNCF | O | CONTINUATION OF FINAL REFUSAL MAILED | Loading... |
| Jan 14, 2008 | CNCF | R | ACTION CONTINUING A FINAL - COMPLETED | Loading... |
| Dec 14, 2007 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Dec 14, 2007 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Dec 14, 2007 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 14, 2007 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Jun 15, 2007 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Jun 14, 2007 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 22, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 21, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 21, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 20, 2006 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Nov 17, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 17, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 20, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; assays and reagents for use in genetic research; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; synthetic peptides for pharmaceutical purposes; testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; medical diagnostic reagents and assays for testing of bodily fluids; contrasting agent for ultrasound diagnostic imaging
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical research and development services, namely, assay development, compound screening, compound ad chemical identification, drug target identification and characterization, performance of human clinical trials
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005
042